| Company Name | ArteraAI |
| Founded | 2021 |
| Head office | Los Altos, California, United States |
| Website | https://artera.ai/ |
| Contact |
Products by ArteraAI
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
No key features available
The ArteraAI Prostate Test can be used for patients across all NCCN risk groups, with 10-year risk of distant metastasis (DM) and prostate cancer-specific mortality (PCSM) reported and can be used to assess how aggressive the cancer is.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
The ArteraAI Breast Cancer Test is designed to deliver prognostic and predictive insights for patients with early-stage HR+ breast cancer to help personalize breast cancer treatment decisions.